The survival prognosis for patients with chronic phase CML has greatly improved since the introduction of TKIs, with some studies showing life expectancy close to the general population. Nonetheless, ...
Mutational profiling is crucial for selecting effective targeted therapies for GIST, replacing broad-spectrum treatments. Localized treatment options, including surgery and ablation, help manage side ...
"Therapeutic innovations like elranatamab achieve a lasting response in 61% of patients with multiple myeloma and complete remission in 30%," said Dr María Victoria Mateos, a consultant physician in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results